A 'Legend' For 50 Years, This Rare Weed Compound Is Finally Popping Up In California Dispensaries

In 1970, University of Oxford researchers unveiled the discovery of tetrahydrocannabivarin (THCV), a unique cannabis compound distinct from the well-known THC and CBD. For decades, its elusive nature conferred it a legendary status, earning denominations like “the sports car of weed” or “weederall.” Its rumored effects include promoting wakefulness and suppressing hunger, attributes that led many to fervently seek it out.

Rare Weed Hits Shelves

Five decades later, the Californian legal cannabis market is witnessing an influx of THCV products. From THCV-infused mints to pre-rolled joints, this rare pot variant is finally accessible to consumers, reports SF Gate.

Two pivotal developments contributed to this surge. Firstly, the 2018 federal legalization of hemp expanded the availability of synthetic cannabinoids, including lab-produced THCV. Secondly, breakthroughs in cultivating cannabis naturally rich in THCV have been achieved.

See also: The 'Father Of Cannabis Research' Discovered Something More Potent Than THC Before Dying: Here's What

Elizabeth Rice of edible maker Kiva highlighted the burgeoning demand in an interview with Lester Black, stating that the cannabis sector has eagerly awaited a consistent supply of THCV for years. Kiva's latest offerings include THCV gummies designed to deliver the stimulation the compound has been associated with.

Proceed With Caution

Despite what was explained above, it’s essential to approach the claims around the effects of THCV with caution. Without comprehensive clinical trials, it's impossible to definitively pinpoint its exact qualities. Initial research suggests that THCV might act counterintuitively on receptors compared to other cannabis compounds. Some trials even indicate potential health benefits, such as appetite suppression and reduced fasting glucose levels, which could be significant for metabolic disorders like diabetes.

See also: Nobel Prize Winner Views Medical Cannabis As 'A Real Therapeutic Treatment...Free Of Mysticism'

Nicole Daryanani, another representative from Kiva, added that THCV comes with a hefty price tag, costing a staggering 10 times more than conventional THC. But thanks to organizations like Phylos Bioscience, a robust supply is emerging. Phylos, an Oregon-based breeding company, has bred cannabis plants with a groundbreaking 20% THCV potency.

With an increasing number of THCV products penetrating the market and ongoing research into its effects, California might soon unlock the mysteries surrounding this rare cannabis compound.

Image: AI

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsMarketsCaliforniaKivaPhylos BioscienceTHCV
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Top Cannabis Event In New Jersey

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!